Salute e Benessere
CPHI & PMEC China Sees Surge in International Attendance as Global Pharma Trade Outlook Strengthens
The event's surge in global interest coincides with easing trade tariffs, improved pharmaceutical valuations, and increased capital expenditure across the sector. International executives are attending in record numbers, seeking new ingredient suppliers and equipment providers in China's robust manufacturing ecosystem.
A notable trend is the growing interest from Western pharmaceutical companies in Chinese biotech assets, not only for domestic market access but also for global licensing opportunities. Concurrently, Middle Eastern participation has increased significantly as Gulf nations implement strategies to establish regional manufacturing hubs, joining larger delegations from India and the United States .
stated Natasha Jennings , Head of Global Growth Marketing.
The event's audience reflects high-level industry engagement, with 80% of international attendees possessing purchasing authority and over 50% holding senior executive positions.
Supplementary programmes include a Natural Extracts Buyer Programme ( June 23rd ) and a Pharma Machinery Buyer Programme ( June 24-25th ). The exhibition will feature the CPHI Celebration Awards, a dedicated conference including the 10th Biopharmaceuticals Outlook Summit, an Innovation Gallery, and regional Plant Visits.
Spanning 230,000+ square metres with 3,500 exhibitors from 150 countries, the event encompasses 12 specialised zones, including new additions for 'BioTech' and 'Fluid & Precision Equipment'.
Jennings added,
To register please attend https://reg.cphi-china.cn/en/user/register
Winnie Xu , winnie.xu@imsinoexpo.com
View original content:https://www.prnewswire.co.uk/news-releases/cphi--pmec-china-sees-surge-in-international-attendance-as-global-pharma-trade-outlook-strengthens-302467067.html